Events > Developments in China’s Healthcare and Life Sciences Sector
row-start col-md-7 #top-section top-section new-section

Developments in China’s Healthcare and Life Sciences Sector

Thursday, 3 September 2020 10:30 am to 11:30 am


Join key officials from the Department for International Trade (DIT) South West and the China Britain Business Council (CBBC) for a comprehensive look at recent developments in the Healthcare and Life Sciences sector in China; exploring what this means for UK companies looking to continue selling to, or advancing further in this fast-growing market.

Register Your Place Now - Click Here

This webinar is the first step for healthcare companies taking a business-focussed approach to reengaging with China and will be followed up by a potential online matchmaking session with Chinese buyers later this year.

Participating companies will also be invited to attend a private online meeting with the CBBC Healthcare Life Science sector lead to discuss in more detail their business plans and ambitions for the Chinese market.

Who is this webinar for?

This webinar is aimed at South West, experienced exporters. Perfect for UK companies and training providers engaged in pharmaceuticals, medical devices, biotech, CROs and Medtech.


  • 10:30 - Introductions – Sarah Hildersley, DIT South West Healthcare Lead
  • 10:35 - Market briefing and update – Jamie Shaw, CBBC Healthcare Life Sciences sector lead
    • An overview of China’s Healthcare Sector
    • Step by step guide for UK businesses seeking to sell in China; top tips and navigating barriers to entry
  • 10:55 - Guest experts on IP and the Chinese regulatory requirements
  • 11:15 - Q&A hosted by Sarah Hildersley
  • 11:30 - Close

The current opportunities

China’s healthcare market is the second largest in the world. The sector faces a wide range of challenges: ongoing urban and rural disparity; an ageing population and the rising burden of non-communicable diseases. These difficulties, in line with continued improvement of living standards and rising household disposable income, provide opportunities for UK companies seeking to grow their export business in the Chinese market.
The Chinese government is firmly committed to healthcare development and it remains a key part of the National Strategy, as demonstrated by the Healthy China 2030 planning outline which has an ever liberalising approach to market and regulatory access. This was well evidenced in 2017 for example, with 50% of China’s $52 billion medical device market accounted for by imports. The UK’s capabilities in healthcare-related goods and services provide an ideal match for China’s national healthcare objective.

Register Your Place Now - Click Here

Please Note: We will send you details of the online platform and login details prior to the event.

row-end col-sm-12 col-md-5
row-start col-xs-12 colour-section row-end


Sarah Hildersley
With extensive business development experience as a British diplomat all over the world helping UK companies achieve sales success, and private sector experience from Iraq, Sarah now advises South West companies on their approach to selling in complex markets in Asia, Latin America and the Middle East.  Having worked extensively with small businesses and some of the largest UK firms, Sarah is well placed to help our companies secure sales in the most efficient way.  Sarah helps companies analyse their route to market and to secure sustainable sales.  She recently took on the expanded role of High Growth Markets Specialist in recognition of our levelling-up plans to help South West companies break into new markets.  http://www.linkedin.com/in/sarahhildersley

Jamie Shaw
Jamie is the Life Sciences Sector Lead for the China-Britain Business Council, helping to support and advise businesses on their Chinese export strategies.  Jamie has extensive experience of working in China, previously based in Shenzhen he was an Account Manager for Mindray, a global player and the country’s largest medical device manufacturer. Prior to this he was a Retail Buyer, spending significant time in Chinese factories sourcing product and managing the associated supply chain on behalf of his UK retail clients.  Jamie holds a scholarship MBA from Shanghai Jiao Tong University and International Business masters from the University of Leeds.

Graeme McCallum

Graeme McCallum is a qualified UK and European patent attorney and trade mark attorney and an IP Litigator. He has over 20 years experience helping clients to protect and enforce their intellectual property rights.

Graeme has a broad range of experience in different medical related technologies, including surgical instruments, stents and grafts, catheters, NMR imaging, drug delivery systems and anti-bacterial compositions as well as more general healthcare technologies such as monitors, beds and mattresses.

Graeme has substantial experience of assisting start-ups and SMEs, as well as managing the IP portfolios of multi-national corporations. He assists clients to extract maximum value from their innovations and to ensure that their IP strategies are aligned with their business strategies and work to support the business. He has particular expertise in handling high value and standards related patent cases.

Anna King 
Anna attained degrees with distinction in Natural Sciences (BSc) and China Business (MSc) in England and Hong Kong and has been working for Cisema group since 2013. She has been advising companies on China certification as a business consultant of Cisema in Munich, Beijing and Hong Kong. Mrs. King currently resides in Hong Kong and has specialised in NMPA (former CFDA) registration of medical devices, cosmetics, and other life science products.

Brief company intro:
Cisema is a turn-key regulatory affairs solutions provider for China and Hong Kong for medical device, IVD, pharmaceutical packaging & APIs and cosmetics manufacturers. Founded in 2002 in Munich, Germany and Beijing, China, we have offices globally. We’re a one-stop service provider supporting UK and global companies register their products for sale in China. Cisema also provides post-market surveillance support and can act as legal agent so you don't have to set up an office in China.







We take your data very seriously and are committed to the privacy and security of it. This event is organised by Business West, delivery partner for The Department of International Trade for the SW, together with the China Britain Business Council. The data collected will be shared with these organisations for processing your booking, managing and following up the event.

The event is delivered on behalf of the Department for International Trade and their privacy policies are available at  DIT Personal Information Charter.

The China Britain Business Council privacy policies are available at http://www.cbbc.org/home/privacy-policy/